
Navigating the IPR maze
The Indian Patent Office’s decision to grant the patent for Gilead’s Hepatitis C treatment drug, Sovaldi, has attracted much criticism. This change of heart — given the rejection of the same patent application in …
Read MoreGlobal Indian News
The Indian Patent Office’s decision to grant the patent for Gilead’s Hepatitis C treatment drug, Sovaldi, has attracted much criticism. This change of heart — given the rejection of the same patent application in …
Read MoreAnnouncing a comprehensive National Intellectual Property Rights (IPR) policy to incentivise entrepreneurship, creativity and innovation, India said on May 13 that its IPR laws are WTO-compliant.
Read More